Lenalidomide + Azacitidine for Adaptive Immunotherapy -> Auto SCT in Multiple Myeloma

NCT01050790 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Azacitidine

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]
[object Object]